Pfizer Inc. announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age or older. The FDA decision is primarily […]
Respiratory
Caire Portable O2 Concentrator Outperforms Competing Devices
CAIRE’s premier portable oxygen concentrator, the FreeStyle® Comfort®, outperformed other market-leading devices in a recent study designed to assess the effectiveness of these devices in delivering oxygen to patients. The study, “Comparison of portable oxygen concentrators using a COPD patient simulation model,” was conducted by Rachel Culbreth, Ph.D., MPH, RRT; Robert […]
Vitalograph AIM Improves Inhaler Technique
With independent studies showing that 8 out of 10 people use their inhalers incorrectly1, inhaler technique training supports more accurate drug delivery, helping patients get the full benefit of their medication, and resulting in better disease management. The Vitalograph AIM™ (Aerosol Inhalation Monitor) is designed to assist medical practitioners in […]
Vyaire Medical Issues Voluntary Correction for Certain bellavista Ventilators
In December 2021, imtmedical ag, a subsidiary of Vyaire Medical, initiated a voluntary field correction for certain bellavista™ ventilators. With specific software version and configuration combinations, the ventilators can cease ventilation and generate a technical failure alarm 305. There is a potential issue with bellavista™ 1000 and 1000e ventilators that […]
New Study Reveals Young E-Cigarette Users Develop Wheezing, Other Respiratory Symptoms
A new study funded by the American Lung Association reveals that young adults who used e-cigarettes were more likely to develop respiratory issues within one year of vaping. The study, titled, “Association of Electronic Cigarette Use with Respiratory Symptom Development among US Young Adults,” will be published in the American Journal of Respiratory and Critical Care Medicine, one […]
Puritan Bennett 980 Series Ventilator Recall
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Product Names: Puritan Bennett 980 Series Ventilator Model Numbers: See Recall Database Entries Distribution Dates: February 23, 2017 to April 4, 2020 […]
Meeting ATS-Recommended Air Quality Standards Would Save Thousands of Lives
A paper published online in the Annals of the American Thoracic Society presents research discussing how new air quality standards recommended by the American Thoracic Society have the potential to prevent more illness and death than standards adopted by the U.S. Environmental Protection Agency (EPA). This study is part of the […]
New Clinical Practice Guideline on FeNO to Help Guide Asthma Treatment
In its latest clinical practice guideline on evaluation and treatment of asthma, an American Thoracic Society expert guidelines panel has addressed the use of fractional exhaled nitric oxide (FeNO) to guide the treatment of asthma. The guideline was published online in the Nov. 15 issue of the American Journal of Respiratory and Critical […]
Bipartisan Congressional Bill Introduced to Honor Respiratory Therapists
Congressman Jamie Raskin (MD) introduced a bipartisan resolution recognizing the significant contributions that respiratory therapists have made during the COVID-19 pandemic. The introduction of the bipartisan resolution falls during National Respiratory Care Week and demonstrates Congress’s continued support for the exceptional respiratory therapists who live and work in our communities. […]
E-Cigarettes a Harm Reduction Tool? ATS Doesn’t Think So
“The ATS reiterates our long-held position – e-cigarettes are not “safe” and the claims that e-cigarettes are a harm reduction tool remain unproven. All e-cigarettes have significant health risks including nicotine addiction and respiratory disease,” said ATS President Lynn Schnapp, MD, ATSF. The ATS notes that the FDA has finally issued decisions […]


















